JW Shinyak announced on the 5th that it donated pharmaceuticals to the Korean Red Cross to support the people of Sri Lanka who are struggling due to the national default crisis.


JW Shinyak announced on the 5th that it donated pharmaceuticals to the Korean Red Cross to support the people of Sri Lanka who are struggling due to the national default crisis, at the request of the Korea Anti-Drug Association (KAADA). Kim Pil-yeo, Chairman of the Korea Anti-Drug Association, is taking a commemorative photo for the donation of pharmaceuticals. <br>[Photo by JW Shinyak]

JW Shinyak announced on the 5th that it donated pharmaceuticals to the Korean Red Cross to support the people of Sri Lanka who are struggling due to the national default crisis, at the request of the Korea Anti-Drug Association (KAADA). Kim Pil-yeo, Chairman of the Korea Anti-Drug Association, is taking a commemorative photo for the donation of pharmaceuticals.
[Photo by JW Shinyak]

View original image

The company explained that this pharmaceutical support was made at the request of the Korea Anti-Drug Abuse Association (KAADA). JW Shinyak delivered over 10,000 specialized medicines, including the antibiotic 'Omacef' and the gastroesophageal reflux disease treatment 'Laberose,' to the Korean Red Cross. These medicines will be distributed to local medical facilities through the Korean Red Cross to be used for patients who cannot receive treatment due to a shortage of medicines.



Kim Yong-gwan, CEO of JW Shinyak, said, "We hope this will help heal the wounds of the people of Sri Lanka who are facing difficulties such as rising prices caused by the national default crisis."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing